Humachag, Jea G.
HRN: 05-93-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/29/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/29/2024
03/07/2024
IV
600mg
Q6
Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes